Indegene Limited
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 25.6%
Concerns0
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 7 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.09 K Cr | β | βΉ181.00 Cr | β | β | 9.6% | 4.6% | 31.2% |
| Mar 2024 | βΉ1.05 K Cr | β | βΉ138.00 Cr | β | β | 14.5% | 4.0% | 6.2% |
| Mar 2023 | βΉ1.01 K Cr | β | βΉ130.00 Cr | β | β | 16.4% | 20.2% | -2.3% |
| Mar 2022 | βΉ837.00 Cr | β | βΉ133.00 Cr | β | β | 20.4% | 63.8% | 0.8% |
| Mar 2021 | βΉ511.00 Cr | β | βΉ132.00 Cr | β | β | 51.9% | 53.0% | 312.5% |
| Mar 2020 | βΉ334.00 Cr | β | βΉ32.00 Cr | β | β | -1185.2% | 18.4% | -37.3% |
| Mar 2019 | βΉ282.00 Cr | β | βΉ51.00 Cr | β | β | 32.2% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 1,116 |
| Total Expenses | 917 |
| EBIT / Operating Profit | 199 |
| OPM % | 18% |
| Other Income | 107 |
| Finance Costs | 7 |
| Depreciation & Amortisation | 29 |
| Profit Before Tax | 270 |
| Tax % | - |
| Net Profit / PAT | 209 |
| EPS (βΉ) | 8.71 |
| Dividend Payout % | - |
Peer Comparison
Technology sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Indegene Limitedthis co. | βΉ12.31 K Cr | βΉ1.09 K Cr | 58.90 | 6.25 | 56.14 | 4.6% |
| Bharti Airtel Ltd. | βΉ12.19 L Cr | βΉ1.09 L Cr | 50.40 | 8.31 | 27.19 | 15.8% |
| Tata Consultancy Services Ltd. | βΉ11.84 L Cr | βΉ2.15 L Cr | 24.20 | 13.91 | 18.91 | 6.2% |
| Infosys Ltd | βΉ6.48 L Cr | βΉ1.37 L Cr | 24.20 | 7.17 | 16.31 | 5.9% |
| HCL Technologies Ltd | βΉ4.52 L Cr | βΉ51.10 K Cr | 36.80 | 14.48 | β | 6.2% |
| Bharat Electronics Ltd. | βΉ3.02 L Cr | βΉ23.66 K Cr | 53.30 | 14.23 | 51.32 | 17.3% |
| Wipro Ltd. | βΉ2.77 L Cr | βΉ67.29 K Cr | 23.00 | 4.29 | 18.85 | 0.8% |
| Industry Average | β | βΉ10.05 K Cr | 69.99 | 8.58 | 66.75 | 22.0% |